亚洲国产成人久久77-亚洲国产成人久久99精品-亚洲国产成人久久精品hezyo-亚洲国产成人久久精品动漫-人妖hd-人妖ts在线,一本道高清DVD在线视频,2020亚洲永久精品导航,国产久久视频在线视频观看

當(dāng)前位置： 首頁 JCRQ1 期刊介紹(非官網(wǎng))
Dermatology And Therapy

Dermatology And TherapySCIE

國際簡稱：DERMATOLOGY THER  參考譯名：皮膚科和治療

  • 中科院分區(qū)

    3區(qū)

  • CiteScore分區(qū)

    Q1

  • JCR分區(qū)

    Q1

基本信息：
ISSN：2193-8210
E-ISSN：2190-9172
是否OA：開放
是否預(yù)警：否
TOP期刊：否
出版信息：
出版地區(qū)：Germany
出版商：Springer Healthcare
出版語言：English
出版周期：12 issues per year
出版年份：2011
研究方向：Medicine-Dermatology
評價信息：
影響因子：3.5
CiteScore指數(shù)：6
SJR指數(shù)：1.424
SNIP指數(shù)：1.328
發(fā)文數(shù)據(jù)：
Gold OA文章占比：98.75%
研究類文章占比：75.94%
年發(fā)文量：187
自引率：0.0882...
開源占比：0.992
出版撤稿占比：0
出版國人文章占比：0.04
OA被引用占比：1
英文簡介 期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Dermatology And Therapy期刊介紹

Dermatology and Therapy is an international, open access, peer-reviewed, rapid publication journal (peer review in 2 weeks, published 3–4 weeks from acceptance). The journal is dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of dermatological therapies. Studies relating to diagnosis, pharmacoeconomics, public health and epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to all clinical aspects of dermatology, such as skin pharmacology; skin development and aging; prevention, diagnosis, and management of skin disorders and melanomas; research into dermal structures and pathology; and all areas of aesthetic dermatology, including skin maintenance, dermatological surgery, and lasers.

The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/case series, trial protocols, and short communications. Dermatology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an International and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals. The journal appeals to a global audience and receives submissions from all over the world.

期刊簡介Dermatology And Therapy期刊介紹

《Dermatology And Therapy》自2011出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進醫(yī)學(xué)領(lǐng)域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報道醫(yī)學(xué)領(lǐng)域的最新進展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關(guān)注點：

Cite Score數(shù)據(jù)（2024年最新版）Dermatology And Therapy Cite Score數(shù)據(jù)

  • CiteScore：6
  • SJR：1.424
  • SNIP：1.328
學(xué)科類別 分區(qū) 排名 百分位
大類：Medicine 小類：Dermatology Q1 17 / 142

88%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻計量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Dermatology And Therapy 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否
大類學(xué)科 分區(qū) 小類學(xué)科 分區(qū)
醫(yī)學(xué) 3區(qū) DERMATOLOGY 皮膚病學(xué) 3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運用科學(xué)計量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進行等級劃分的期刊評價標(biāo)準(zhǔn)。它為我國科研、教育機構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機構(gòu)的廣泛認可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Dermatology And Therapy JCR分區(qū)

2023-2024 年最新版
按JIF指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科：DERMATOLOGY SCIE Q1 20 / 94

79.3%
按JCI指標(biāo)學(xué)科分區(qū) 收錄子集 分區(qū) 排名 百分位
學(xué)科：DERMATOLOGY SCIE Q1 19 / 94

80.32%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻質(zhì)量進行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計
  • 國家/地區(qū)數(shù)量
  • USA108
  • Italy41
  • Spain28
  • France27
  • GERMANY (FED REP GER)26
  • England22
  • CHINA MAINLAND18
  • Poland18
  • Belgium14
  • Canada12

本刊中國學(xué)者近年發(fā)表論文

  • 1、Design of Effisayil (TM) 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis

    Author: Morita, Akimichi; Choon, Siew Eng; Bachelez, Herve; Anadkat, Milan J.; Marrakchi, Slaheddine; Zheng, Min; Tsai, Tsen-Fang; Turki, Hamida; Hua, Harry; Rajeswari, Sushmita; Thoma, Christian; Burden, A. David

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 347-359. DOI: 10.1007/s13555-022-00835-6

  • 2、Effect of 30% Supramolecular Salicylic Acid Peel on Skin Microbiota and Inflammation in Patients with Moderate-to-Severe Acne Vulgaris

    Author: Shao, Xinyi; Chen, Yangmei; Zhang, Lingzhao; Zhang, Yujie; Ariyawati, Asoka; Chen, Tingqiao; Chen, Jiayi; Liu, Lin; Pu, Yihuan; Li, Yuxin; Chen, Jin

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 155-168. DOI: 10.1007/s13555-022-00844-5

  • 3、Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry

    Author: Yu, Chen; Wang, Gang; Burge, Russel T.; Ye, Erjia; Dou, Guanshen; Li, Jinnan; Harrison, Ryan W.; McLean, Robert R.; Kerti, Samantha J.; Bagel, Jerry

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 187-206. DOI: 10.1007/s13555-022-00843-6

  • 4、Application of Comfort Therapy under eCASH Concept in Acute and Chronic Wound Treatment

    Author: Shi, Shuting; Wei, Jiayu; Lyu, Guozhong; Zhong, Xiaohui; Zhu, Lihong; Yang, Minlie

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 1, pp. 299-314. DOI: 10.1007/s13555-022-00852-5

  • 5、Effectiveness and Safety of Guselkumab for the Treatment of Psoriasis in Real-World Settings at 52 weeks: A Retrospective, Observational, Multicenter Study from China

    Author: Yang, Jing; Hu, Kun; Li, Xingyu; Hu, Jingjin; Tan, Minjia; Zhang, Mi; Kuang, Yehong; Lv, Chengzhi; Chen, Junchen

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 477-485. DOI: 10.1007/s13555-022-00869-w

  • 6、Efficacy, Safety and Pharmacokinetics of IL-17 Monoclonal Antibody Injection (AK111) in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blinded, Placebo-Controlled Phase Ib Multidose Escalation Clinical Study

    Author: Jiang, Congjun; Zhou, Huan; Zhang, Wanlu; Xia, Yu; Li, Baiyong; Ni, Xiang; Wang, Guoqin; Zhang, Wenhui; Chen, Benchao; He, Zhimei; Zhang, Min; Chen, Rui; Jin, Hongzhong; Deng, Liehua

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 555-567. DOI: 10.1007/s13555-022-00880-1

  • 7、An Intelligent Diagnostic Model for Melasma Based on Deep Learning and Multimode Image Input

    Author: Liu, Lin; Liang, Chen; Xue, Yuzhou; Chen, Tingqiao; Chen, Yangmei; Lan, Yufan; Wen, Jiamei; Shao, Xinyi; Chen, Jin

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 2, pp. 569-579. DOI: 10.1007/s13555-022-00874-z

  • 8、Pimecrolimus for the Treatment of Atopic Dermatitis in Infants: An Asian Perspective

    Author: Chu, Chia-Yu; Yao, Tsung-Chieh; Shih, I. -Hsin; Yang, Chin-Yi; Chin, Chan Lee; Ibrahim, Sabeera Begum Binti Kader; Thevarajah, Suganthi; Fon, Leong Kin; Ho, Marco Hok-Kung; Mo, Chow Chung; Yu, Chow Pok; Loo, Steven King-Fan; Luger, Thomas

    Journal: DERMATOLOGY AND THERAPY. 2023; Vol. 13, Issue 3, pp. 717-727. DOI: 10.1007/s13555-022-00886-9

投稿常見問題

通訊方式：5 THE WAREHOUSE WAY, NORTHCOTE, NEW ZEALAND, AUCKLAND, 0627。